Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102213 | 12610221 | 3 | F | 20160711 | 20160819 | 20160801 | 20160823 | EXP | GB-MYLANLABS-2016M1030209 | MYLAN | 0.00 | Y | 0.00000 | 20160823 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126102213 | 12610221 | 1 | PS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | U | U | 91226 | ||||||||
| 126102213 | 12610221 | 2 | SS | BETAHISTINE | BETAHISTINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 3 | SS | BISOPROLOL | BISOPROLOL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 4 | SS | MONTELUKAST | MONTELUKAST SODIUM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 5 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 6 | SS | PREGABALIN. | PREGABALIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 7 | SS | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 8 | SS | THIAMINE MYLAN | THIAMINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 9 | SS | ZOPICLONE | ZOPICLONE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 10 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 11 | SS | ELIQUIS | APIXABAN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 12 | SS | FERROUS GLUCONATE | FERROUS GLUCONATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 13 | SS | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 14 | SS | LINAGLIPTIN | LINAGLIPTIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 15 | C | UMECLIDINIUM | UMECLIDINIUM BROMIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126102213 | 12610221 | 16 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126102213 | 12610221 | 1 | Product used for unknown indication |
| 126102213 | 12610221 | 2 | Product used for unknown indication |
| 126102213 | 12610221 | 3 | Product used for unknown indication |
| 126102213 | 12610221 | 4 | Product used for unknown indication |
| 126102213 | 12610221 | 6 | Product used for unknown indication |
| 126102213 | 12610221 | 9 | Product used for unknown indication |
| 126102213 | 12610221 | 10 | Product used for unknown indication |
| 126102213 | 12610221 | 11 | Product used for unknown indication |
| 126102213 | 12610221 | 12 | Product used for unknown indication |
| 126102213 | 12610221 | 13 | Product used for unknown indication |
| 126102213 | 12610221 | 14 | Product used for unknown indication |
| 126102213 | 12610221 | 15 | Product used for unknown indication |
| 126102213 | 12610221 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126102213 | 12610221 | HO |
| 126102213 | 12610221 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126102213 | 12610221 | Cough | |
| 126102213 | 12610221 | Lethargy | |
| 126102213 | 12610221 | Sputum discoloured |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |